ENVB NASDAQ
Enveric Biosciences, Inc.
1W: -1.3%
1M: +2.8%
3M: +0.0%
YTD: -59.7%
1Y: -81.4%
3Y: -99.6%
5Y: -100.0%
$1.48
+0.02 (+1.37%)
Weekly Expected Move ±6.4%
$1
$1
$1
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$6.6M
52W Range1.17-13.25
Volume72,438
Avg Volume134,138
Beta1.11
Dividend—
Analyst Ratings
Company Info
CEOJoseph Edward Tucker
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2015-05-04
Websiteenveric.com
245 First Street
Cambridge, MA 02142
US
Cambridge, MA 02142
US
239 302 1707
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Latest News
Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health Therapies
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
What's Going On With Enveric Biosciences Stock On Friday?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| DeWitt Sheila | A-Award | 7,633 | — | 2025-12-23 |
| Kegler George A. | A-Award | 7,633 | — | 2025-12-23 |
| PASQUALONE FRANK | A-Award | 7,633 | — | 2025-12-23 |
| Schabacker Marcus | A-Award | 7,633 | — | 2025-12-23 |
| Tucker Joseph Edward | A-Award | 60,296 | — | 2025-12-23 |